Nitric oxide released by lactobacillus farciminis improvesTNBS‐induced colitis in rats

References

• Boughton-Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Lancet 1993;342:338–40.
   Google Scholar
• Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Gut 1995;36:718–23.
   PubMed Web of Science ®Google Scholar
• Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998;42:180–7.
   PubMed Web of Science ®Google Scholar
• Herulf M, Ljung T, Hellstrom PM, Weitzberg E, Lundberg JO. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998;33:164–9.
   Google Scholar
• Rachmilewitz D, Karmeli F, Okon E. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995;109:98–106.
   Google Scholar
• Kankuri E, Vaali K, Knowles RG, Lahde M, Korpela R, Vapaatalo H, et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. J Pharmacol Exp Ther 2001; 298:1128–32.
   PubMed Web of Science ®Google Scholar
• Zingarelli B, Szabo C, Salzman A. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999;45:199–209.
   Google Scholar
• Ribbons KA, Currie MG, Connor JR, Manning PT, Allen PC, Didier P, Ratterree MS, Clark DA, Miller MJ. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther 1997;280:1008–15.
   Google Scholar
• McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999;45:864–73.
   Google Scholar
• Dikopoulos N, Nussler AK, Liptay S, Bachem M, Reinshagen M, Stiegler M, et al. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest 2001;31:234–9.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Vergnolle N, Muscara MN, Asfaha S, Chapman K, McKnight W, et al. Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology 1999;117:557–66.
   PubMed Web of Science ®Google Scholar
• MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869–76.
   Google Scholar
• Kitagawa H, Takeda F, Kohei H. Effect of endothelium-derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Ther 1990;253:1133–7.
   Google Scholar
• Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut 2002;51: 405–9.
   PubMed Web of Science ®Google Scholar
• Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 1999;116:1246–9.
   PubMed Web of Science ®Google Scholar
• Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn’s disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 1996; 40:137–45.
   PubMed Web of Science ®Google Scholar
• Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Doubleblind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997;11:853–8.
   PubMed Web of Science ®Google Scholar
• Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354:635–9.
   Google Scholar
• Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 2000;45:1462–4.
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:305–9.
   PubMed Web of Science ®Google Scholar
• Fabia R, Ar’Rajab A, Johansson ML, Willen R, Andersson R, Molin G, et al. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 1993;28:155–62.
   PubMed Web of Science ®Google Scholar
• Mao Y, Nobaek S, Kasravi B, Adawi D, Stenram U, Molin G, et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 1996;111:334–44.
   PubMed Web of Science ®Google Scholar
• Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116: 1107–14.
   Google Scholar
• Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580–91.
   PubMed Web of Science ®Google Scholar
• Marteau P, Pochart P, Bouhnik Y, Rambaud JC. The fate and effects of transiting, nonpathogenic microorganisms in the human intestine. World Rev Nutr Diet 1993;74:1–21.
   PubMedGoogle Scholar
• Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000;289:1352–5.
   PubMed Web of Science ®Google Scholar
• Wolf G, Arendt EK, Pfahler U, Hammes WP. Heme-dependent and heme-independent nitrite reduction by lactic acid bacteria results in different N-containing products. Int J Food Microbiol 1990;10:323–9.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Keenan CM, Gale D, Shoupe TS. Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology 1992;102:18–27.
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78: 206–9.
   PubMed Web of Science ®Google Scholar
• Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun 1992;185:960–6.
   PubMed Web of Science ®Google Scholar
• Vanin AF, Kleschyov AL. EPR studies and biological implications of nitrosyl nonheme iron complexes. In: Lukiewicz S, Zweier JL editors. Nitric oxide in transplant rejection and antitumor defence. London: Kluwer; 1998. p. 49–82.
   Google Scholar
• Kleschyov AL, Mollnau H, Oelze M, Meinertz T, Huang Y, Harrison DG, et al. Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem Biophys Res Commun 2000;275:672–7.
   PubMed Web of Science ®Google Scholar
• MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869–76.
   Google Scholar
• Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651–5.
   PubMed Web of Science ®Google Scholar
• Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 1996; 93:9114–9.
   Google Scholar
• Wong PY, Yue G, Yin K, Miyasaka M, Lane CL, Manning AM, et al. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J Pharmacol Exp Ther 1995;274:475–80.
   PubMed Web of Science ®Google Scholar
• Miller MJ, Thompson JH, Zhang XJ, Sadowska-Krowicka H, Kakkis JL, Munshi UK, et al. Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 1995;109:1475–83.
   Google Scholar
• Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, et al. Peroxynitrite-induced rat colitis: a new model of colonic inflammation. Gastroenterology 1993;105:1681–8.
   PubMed Web of Science ®Google Scholar
• Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271:40–7.
   PubMed Web of Science ®Google Scholar
• Wink DA, Cook JA, Kim SY, Vodovotz Y, Pacelli R, Krishna MC, et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997;272:11147–51.
   Google Scholar
• Schiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 1992;298:446–51.
   Google Scholar
• Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, Feelisch M. No NO from NO synthase. Proc Natl Acad Sci USA 1996;93:14492–7.
   PubMed Web of Science ®Google Scholar
• Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111:871–85.
   PubMed Web of Science ®Google Scholar
• Craven PA, Pfanstiel J, DeRubertis FR. Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation. J Clin Invest 1986;77:850–9.
   Google Scholar
• Perner A, Andresen L, Pedersen G, Rask-Madsen J. Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells. Gut 2003; 52: 231–6.
   Google Scholar
• Oshitani N, Kitano A, Okabe H, Nakamura S, Matsumoto T, Kobayashi K. Location of superoxide anion generation in human colonic mucosa obtained by biopsy. Gut. 1993;34:936–8.
   PubMed Web of Science ®Google Scholar
• Jourd’heuil D, Kang D, Grisham MB. Interactions between superoxide and nitric oxide: implications in DNA damage and mutagenesis. Front Biosci 1997;2:189–96.
   Google Scholar
• Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E. Induction of iNOS in a rat model of acute colitis. Inflammation 1999;23:141–52.
   Google Scholar
• Ravichandran LV, Johns RA, Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 1995;268:H2216–23.
   Google Scholar
• Mariotto S, Cuzzolin L, Adami A, Del Soldato P, Suzuki H, Benoni G. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils. Br J Pharmacol 1995;114:1105–6.
   Google Scholar
• Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448–55.
   Google Scholar
• Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365–75.
   Google Scholar
• Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66: 5224–31.
   PubMed Web of Science ®Google Scholar
• Garcia-Lafuente A, Antolin M, Guarner F, Crespo E, Salas A, Forcada P, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997;272:G10–5.
   Google Scholar
• Neut C, Guillemot F, Colombel JF. Nitrate-reducing bacteria in diversion colitis: a clue to inflammation? Dig Dis Sci 1997;42: 2577–80.
   Google Scholar
• Roediger WE, Radcliffe BC. Role of nitrite and nitrate as a redox couple in the rat colon. Implications for diarrheal conditions. Gastroenterology 1988;94:915–22.
   PubMed Web of Science ®Google Scholar
• Unno N, Wang H, Menconi MJ, Tytgat SH, Larkin V, Smith M, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113:1246–57.
   PubMed Web of Science ®Google Scholar
• Kavuklu B, Agalar C, Guc MO, Sayek I. Evidence that aminoguanidine inhibits endotoxin-induced bacterial translocation. Br J Surg 1998;85:1103–6.
   PubMed Web of Science ®Google Scholar
• Fang FC. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818–25.
   PubMed Web of Science ®Google Scholar
• De Groote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Infect Dis 1995;21 Suppl 2:162S–5S.
   Google Scholar